Search

The article discusses the importance of electrocardiogram (ECG) reading on clinical research and practice. It stresses that it is critical in data collection during clinical research with the investigational drug's cardiac safety profile, especially the interval duration measurements of heart activity, emphasizing ECG centralization. It suggests that relevance of the findings should also be associated with one's prior history and current health status.

The article discusses the scientific approach in the centralization of electrocardiogram (ECG) Phase III on cardiac safety risk assessment. It emphasizes the QT wave interval prolongation, or the contraction and repolarization of cardiac muscles, on polymorphic ventricular tachycardia or torsades de pointes during drug interaction. The clinical trial "Thorough QT/QTc (TQT) Study" promotes cardiac safety data collection associated with market drugs and further enhances assessment.